iSpecimen Inc. SEC filings ISPC
iSpecimen Inc. has 333 filings in SEC EDGAR's recent list, going back to Sep 25, 2012. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, acquisition or sale of assets, unregistered share sale, change in control, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Apr 14, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Jun 10, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 10, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 21, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 22, 2022 | Dec 31, 2021 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ISPC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woburn, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1558569
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.